Cross Country Healthcare (CCRN)
(Delayed Data from NSDQ)
$12.33 USD
+0.15 (1.23%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $12.33 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth A Momentum A VGM
Income Statements
Fiscal Year end for Cross Country Healthcare, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 2,020 | 2,807 | 1,677 | 836 | 822 |
Cost Of Goods | 1,569 | 2,179 | 1,302 | 634 | 618 |
Gross Profit | 450 | 628 | 375 | 203 | 204 |
Selling & Adminstrative & Depr. & Amort Expenses | 338 | 355 | 236 | 212 | 220 |
Income After Depreciation & Amortization | 113 | 273 | 139 | -9 | -16 |
Non-Operating Income | -2 | -2 | 1 | 0 | -3 |
Interest Expense | 8 | 14 | 7 | 3 | 5 |
Pretax Income | 103 | 256 | 133 | -12 | -24 |
Income Taxes | 30 | 68 | 1 | 0 | 32 |
Minority Interest | 0 | 0 | 0 | 1 | 2 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 73 | 188 | 132 | -12 | -56 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 73 | 188 | 132 | -13 | -58 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 131 | 286 | 149 | 4 | -1 |
Depreciation & Amortization (Cash Flow) | 18 | 13 | 10 | 13 | 15 |
Income After Depreciation & Amortization | 113 | 273 | 139 | -9 | -16 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 35.48 | 37.54 | 37.39 | 36.09 | 35.82 |
Diluted EPS Before Non-Recurring Items | 2.23 | 5.27 | 3.06 | 0.46 | 0.15 |
Diluted Net EPS (GAAP) | 2.05 | 5.02 | 3.53 | -0.36 | -1.61 |
Fiscal Year end for Cross Country Healthcare, Inc falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | NA | 339.77 | 379.17 | 414.04 | 442.29 |
Cost Of Goods | NA | 268.97 | 301.88 | 323.55 | 344.93 |
Gross Profit | NA | 70.80 | 77.30 | 90.49 | 97.36 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 90.01 | 74.37 | 77.06 | 77.06 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -19.21 | 2.93 | 13.43 | 20.30 |
Non-Operating Income | NA | 0.21 | 1.23 | 0.13 | -0.13 |
Interest Expense | NA | 0.57 | 0.46 | 0.59 | 0.67 |
Pretax Income | NA | -19.56 | 3.69 | 12.97 | 19.50 |
Income Taxes | NA | -3.51 | 1.00 | 3.93 | 6.69 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -16.05 | 2.69 | 9.04 | 12.81 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -16.05 | 2.69 | 9.04 | 12.81 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 33.96 | 34.60 | 34.69 | 35.15 |
Diluted EPS Before Non-Recurring Items | NA | 0.10 | 0.19 | 0.29 | 0.39 |
Diluted Net EPS (GAAP) | NA | -0.47 | 0.08 | 0.28 | 0.36 |